Mira Pharmaceuticals, Common Stock Probability of Future Stock Price Finishing Over 1.23
| MIRA Stock | 1.12 0.03 2.61% |
MIRA |
MIRA Pharmaceuticals, Target Price Odds to finish over 1.23
The tendency of MIRA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 1.23 or more in 90 days |
| 1.12 | 90 days | 1.23 | about 64.44 |
Based on a normal probability distribution, the odds of MIRA Pharmaceuticals, to move over 1.23 or more in 90 days from now is about 64.44 (This MIRA Pharmaceuticals, Common probability density function shows the probability of MIRA Stock to fall within a particular range of prices over 90 days) . Probability of MIRA Pharmaceuticals, price to stay between its current price of 1.12 and 1.23 at the end of the 90-day period is about 13.72 .
Given the investment horizon of 90 days MIRA Pharmaceuticals, Common has a beta of -0.78. This indicates as returns on the benchmark increase, returns on holding MIRA Pharmaceuticals, are expected to decrease at a much lower rate. During a bear market, however, MIRA Pharmaceuticals, Common is likely to outperform the market. Additionally MIRA Pharmaceuticals, Common has an alpha of 0.1362, implying that it can generate a 0.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MIRA Pharmaceuticals, Price Density |
| Price |
Predictive Modules for MIRA Pharmaceuticals,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MIRA Pharmaceuticals,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MIRA Pharmaceuticals, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MIRA Pharmaceuticals, is not an exception. The market had few large corrections towards the MIRA Pharmaceuticals,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MIRA Pharmaceuticals, Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MIRA Pharmaceuticals, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.14 | |
β | Beta against Dow Jones | -0.78 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | -0.0096 |
MIRA Pharmaceuticals, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MIRA Pharmaceuticals, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MIRA Pharmaceuticals, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MIRA Pharmaceuticals, generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals, has high historical volatility and very poor performance | |
| MIRA Pharmaceuticals, may become a speculative penny stock | |
| MIRA Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals, generates negative cash flow from operations | |
| MIRA Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: MIRA Pharmaceuticals Validates Ketamir-2s Safety Profile with No Adverse Findings, Paving the Way for IND Submission by Year-End |
MIRA Pharmaceuticals, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MIRA Stock often depends not only on the future outlook of the current and potential MIRA Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MIRA Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 4.6 M |
MIRA Pharmaceuticals, Technical Analysis
MIRA Pharmaceuticals,'s future price can be derived by breaking down and analyzing its technical indicators over time. MIRA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MIRA Pharmaceuticals, Common. In general, you should focus on analyzing MIRA Stock price patterns and their correlations with different microeconomic environments and drivers.
MIRA Pharmaceuticals, Predictive Forecast Models
MIRA Pharmaceuticals,'s time-series forecasting models is one of many MIRA Pharmaceuticals,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MIRA Pharmaceuticals,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about MIRA Pharmaceuticals,
Checking the ongoing alerts about MIRA Pharmaceuticals, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MIRA Pharmaceuticals, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MIRA Pharmaceuticals, generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals, has high historical volatility and very poor performance | |
| MIRA Pharmaceuticals, may become a speculative penny stock | |
| MIRA Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals, generates negative cash flow from operations | |
| MIRA Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: MIRA Pharmaceuticals Validates Ketamir-2s Safety Profile with No Adverse Findings, Paving the Way for IND Submission by Year-End |
Check out MIRA Pharmaceuticals, Backtesting, MIRA Pharmaceuticals, Valuation, MIRA Pharmaceuticals, Correlation, MIRA Pharmaceuticals, Hype Analysis, MIRA Pharmaceuticals, Volatility, MIRA Pharmaceuticals, History as well as MIRA Pharmaceuticals, Performance. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.